|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2010-7-20
|
|
pubmed:abstractText |
Fas (Apo-1/CD95) and its specific ligand (FasL) are key elements in apoptosis. They have been studied in different malignancies but there are few published studies about the soluble forms of these markers (i.e. sFas/sFasL) in gastric cancer. We have compared the serum levels of sFas/sFasL in gastric adenocarcinoma patients and cases with pre-neoplastic lesions as potential markers for early diagnosis, and investigated their relation with clinicopathological characteristics.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-10606894,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-10762649,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-10780525,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-10873098,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11048730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11129423,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11135216,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11182046,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11239407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11466681,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-11485387,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-12050175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-12171883,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-12479070,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-12854132,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-12947554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-14563113,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-15621988,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-15898934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-15970277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-16127223,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-17138222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-18354190,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-18561948,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-18614439,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-18688865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-18941456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-19073863,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-19199904,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-19474385,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-7510905,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-7530337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-7533181,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-8612231,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-8827022,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20534173-9895372
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1471-2407
|
|
pubmed:author |
pubmed-author:AzarianAmir AbbasAA,
pubmed-author:Boroumand-NoughabiSamanehS,
pubmed-author:GhaffarzadehganKamranK,
pubmed-author:HosseinnezhadHaniehH,
pubmed-author:JafarzadehMostafaM,
pubmed-author:MashhadinejadMojtabaM,
pubmed-author:MoavenOmeedO,
pubmed-author:Rajabi-MashhadiMohammad TaghiMT,
pubmed-author:RazieeHamid RezaHR,
pubmed-author:SimaHamid RezaHR,
pubmed-author:Tavakkol-AfshariJalilJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
275
|
|
pubmed:dateRevised |
2010-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:20534173-Adenocarcinoma,
pubmed-meshheading:20534173-Adult,
pubmed-meshheading:20534173-Aged,
pubmed-meshheading:20534173-Antigens, CD95,
pubmed-meshheading:20534173-Case-Control Studies,
pubmed-meshheading:20534173-Chi-Square Distribution,
pubmed-meshheading:20534173-Early Detection of Cancer,
pubmed-meshheading:20534173-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20534173-Fas Ligand Protein,
pubmed-meshheading:20534173-Female,
pubmed-meshheading:20534173-Gastrectomy,
pubmed-meshheading:20534173-Humans,
pubmed-meshheading:20534173-Iran,
pubmed-meshheading:20534173-Male,
pubmed-meshheading:20534173-Middle Aged,
pubmed-meshheading:20534173-Neoplasm Staging,
pubmed-meshheading:20534173-Predictive Value of Tests,
pubmed-meshheading:20534173-Stomach Neoplasms,
pubmed-meshheading:20534173-Treatment Outcome,
pubmed-meshheading:20534173-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
|
|
pubmed:affiliation |
Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
